Syneos Health is the only fully integrated biopharmaceutical solutions organization. Our company, including a Contract Research Organization (CRO) and Contract Commercial Organization (CCO), is purpose-built to accelerate customer performance to address modern market realities. Created through the merger of two industry-leading companies – INC Research and inVentiv Health – we bring together more than 21,000 clinical and commercial minds with the ability to support customers in more than 110 countries. Together we share insights, use the latest technologies and apply advanced business practices to speed our customers’ delivery of important therapies to patients. To learn more about how we are shortening the distance from lab to life visit SyneosHealth.com.

Medidata is the leading global provider of cloud-based solutions for clinical research in life sciences, transforming clinical development through its advanced applications and intelligent data analytics. The Medidata Clinical Cloud™ brings new levels of productivity and quality to the clinical testing of promising medical treatments, from study design and planning through execution, management and reporting. www.mdsol.com

The PPD clinical research business of Thermo Fisher Scientific enables customers to enhance innovation and drug development productivity. Utilizing patient-centered strategies and data analytics, we cover multiple therapeutic areas and include early development, all phases of clinical development, peri- and post-approval, novel approaches to patient recruitment and investigator sites, and comprehensive laboratory services. thermofisher.com/ppd

Advarra is the premier provider of global research compliance services, including IRB, IBC, consulting, and research technology solutions. Clinical trial sponsors and CROs recognize Advarra as the largest integrated provider of IRB services with the greatest institutional reach among health systems, cancer centers, academic medical centers, and investigators. Forte, now part of Advarra, is the industry’s leading provider of standards-based clinical research technology solutions, incorporating a fully integrated suite for clinical trial management, clinical data management, and research administration, including OnCore CTMS. Advarra accelerates study startup and supports better decision-making by providing robust regulatory expertise and insightful data analytics. Advarra also provides opportunities for continuous learning and collaboration, such as the Onsemble Community and conferences, to support best practices and make research altogether better.

Lilly is a global healthcare leader that unites caring with discovery to make life better for people around the world. We were founded more than a century ago by a man committed to creating high quality medicines that meet real needs, and today we remain true to that mission in all our work. Across the globe, Lilly employees work to discover and bring life-changing medicines to those who need them, improve the understanding and management of disease, and give back to communities through philanthropy and volunteerism. To learn more about Lilly, please visit us at www.lilly.com and newsroom.lilly.com/social-channels.

Parexel is among the world’s largest clinical research organizations (CROs), providing the full range of Phase I to IV clinical development services to help life-saving treatments reach patients faster. Leveraging the breadth of our clinical, regulatory and therapeutic expertise, our team of more than 19,000 global professionals works in partnership with biopharmaceutical leaders, emerging innovators and sites to design and deliver clinical trials with patients in mind, increasing access and participation to make clinical research a care option for anyone, anywhere. Our depth of industry knowledge and strong track record gained over the past 40 years is moving the industry forward and advancing clinical research in healthcare’s most complex areas, while our innovation ecosystem offers the best solutions to make every phase of the clinical trial process more efficient. With the people, insight and focus on operational excellence, we work With Heart^TM every day to treat patients with dignity and continuously learn from their experiences, so every trial makes a difference. For more information, visit parexel.com and follow us on LinkedIn, Twitter, Facebook and Instagram. 

The speed, quality, and integrity of endpoint evidence is everything in being able to efficiently advance an experimental therapy forward. Signant is the evidence generation company that helps you digitally enable trials. No matter how or where you run your trials. We make the patient journey more natural and intuitive, and the data journey more direct and objective. With our SmartSignals ecosystem, Signant delivers proof at the speed of life, simplifying and streamlining data generation and reducing the reliance on paper-based evidence gathering and management. We offer vision at a time of change as well as reliability and dependability where it matters most. When the world is counting on you, count on Signant.

4G Clinical is a leader in randomization and trial supply management (RTSM) for the global life sciences industry, offering the only fully cloud-based, 100% configurable and flexible solution utilizing natural language processing (NLP) and integrated supply forecasting. 4G Clinical is headquartered in the Boston Biotech corridor of Wellesley, MA, with offices in Europe and Asia. For more information, visit www.4gclinical.com.

AbbVie is a global, research-driven biopharmaceutical company committed to developing innovative advanced therapies for some of the world’s most complex and critical conditions. The company’s mission is to use its expertise, dedicated people and unique approach to improve treatments and advance health solutions for people around the world. www.abbvie.com

Advarra is the premier provider of global research compliance services, including IRB, IBC, consulting, and research technology solutions. Clinical trial sponsors and CROs recognize Advarra as the largest integrated provider of IRB services with the greatest institutional reach among health systems, cancer centers, academic medical centers, and investigators. Forte, now part of Advarra, is the industry’s leading provider of standards-based clinical research technology solutions, incorporating a fully integrated suite for clinical trial management, clinical data management, and research administration, including OnCore CTMS. Advarra accelerates study startup and supports better decision-making by providing robust regulatory expertise and insightful data analytics. Advarra also provides opportunities for continuous learning and collaboration, such as the Onsemble Community and conferences, to support best practices and make research altogether better.

Headquartered in Fort Worth, Texas, Aspen Insights is a data science and artificial intelligence firm principally engaged in the research, design, development, and integration of healthcare analytics systems, products, and services.

AstraZeneca is a global, innovation-driven biopharmaceutical business that focuses on the discovery, development and commercialization of prescription medicines, primarily for the treatment of cardiovascular, metabolic, respiratory, inflammation, autoimmune, oncology, infection, and neuroscience diseases. AstraZeneca operates in over 100 countries and its innovative medicines are used by millions of patients worldwide. www.astrazeneca.com

Bayer is a global enterprise with core competencies in the Life Science fields of health care and agriculture. Its products and services are designed to benefit people and improve their quality of life. At the same time, the Group aims to create value through innovation, growth and high earning power. Bayer is committed to the principles of sustainable development and to its social and ethical responsibilities as a corporate citizen. In 2016, the Group employed around 115,200 people. For more information, go to www.bayer.com.

As pioneers in neuroscience, Biogen discovers, develops, and delivers worldwide innovative therapies for people living with serious neurological diseases as well as related therapeutic adjacencies. One of the world’s first global biotechnology companies, Biogen was founded in 1978 by Charles Weissmann, Heinz Schaller, Sir Kenneth Murray, and Nobel Prize winners Walter Gilbert and Phillip Sharp. Today, Biogen has the leading portfolio of medicines to treat multiple sclerosis, has introduced the first approved treatment for spinal muscular atrophy, and is providing the first and only approved treatment to address a defining pathology of Alzheimer’s disease. Biogen is also commercializing biosimilars and focusing on advancing the industry’s most diversified pipeline in neuroscience that will transform the standard of care for patients in several areas of high unmet need. The company routinely posts information that may be important to investors on its website at www.biogen.com

Boehringer Ingelheim is committed to improving lives and providing valuable services and support to patients and their families. Our employees create and engage in programs that strengthen our communities. Since its founding in 1885, the company has remained family-owned and today creates value through innovation for three business areas including human pharmaceuticals, animal health and biopharmaceutical contract manufacturing. www.boehringer-ingelheim.com

Bristol-Myers Squibb is a global BioPharma company firmly focused on its mission to discover, develop and deliver innovative medicines to patients with serious diseases. Around the world, our medicines help millions of people in their fight against such diseases as cancer, cardiovascular disease, hepatitis B and hepatitis C, HIV/AIDS and, rheumatoid arthritis. At Bristol-Myers Squibb, our BioPharma strategy uniquely combines the reach and resources of a major pharma company with the entrepreneurial spirit and agility of a successful biotech company. With this strategy, we focus on our customers’ needs, giving maximum priority to accelerating pipeline development. www.bms.com

Clario delivers the leading endpoint technology solutions for clinical trials. Through experience gained from over 19,000 clinical trials delivered in support of 870 regulatory approvals, Clario fuses scientific expertise and global scale into the broadest endpoint technology platform to enable pharmaceutical, biotech and medical device partners to transform lives. Through Trial Anywhere™, Clario has mastered the ability to generate rich evidence across all trial models: decentralized, hybrid and site-based clinical trials. With 30 facilities in nine countries across North America, Europe and Asia Pacific, Clario’s global team of science, technology and operational experts has been delivering the richest clinical evidence for nearly 50 years.

Clinerion accelerates clinical research and medical access to treatments for patients. We generate real-world data from our global network of partner hospitals for Real World Evidence analyses. Clinerion’s Patient Network Explorer radically improves the efficiency and effectiveness of clinical trial recruitment by offering data-driven protocol optimization, site feasibility evaluation and real-time patient search and identification to match patients to treatments. Clinerion facilitates the participation of partner hospitals in leading-edge, industry-sponsored trials and time savings in patient recruitment. Researchers gain access to real-time, longitudinal patient data from electronic health records for analysis. We enable pharmaceutical companies, CROs and SMOs to shorten patient recruitment and save costs by streamlining operations and leveraging strategic intelligence. Clinerion’s Patient Network Explorer also provides a platform for integration of diverse patient data sources into real-world data ecosystems. Clinerion’s proprietary technologies comply with international patient privacy and data security regulations. Clinerion is a global data technology service company headquartered in Switzerland.

Clinical ink is the global life science company that brings data, technology, and patient science together.

Our deep therapeutic-area expertise, coupled with Direct Data Capture, eCOA, eConsent, telehealth, neurocognitive testing,
and digital biomarkers advancements, drive the industry standard for data precision and usher in a new generation of clinical trials.

By harnessing digital data, we power sponsors, CROs, researchers, and patients to recenter decentralized trials and rewrite the clinical development experience.

Cognizant partners with biopharmaceutical and med-tech companies to develop strategies and apply solutions to healthcare challenges across the value chain. Our platforms and services are digitizing interactions between sponsors, investigators, patients, and regulators across every phase, helping the industry subtract time from clinical development and add it to patient lives. To learn more, visit www.cognizant.com.

CSL Behring is a global biotherapeutics leader driven by our promise to save lives. Focused on serving patients’ needs by using the latest technologies, we discover, develop and deliver innovative therapies for people living with conditions in the immunology, hematology, cardiovascular and metabolic, respiratory, and transplant therapeutic areas. We use three strategic scientific platforms of plasma fractionation, recombinant protein technology, and cell and gene therapy to support continued innovation and continually refine ways in which products can address unmet medical needs and help patients lead full lives.

Curebase is reinventing decentralized clinical trials to help the vast majority of potential patients that currently cannot access clinical research. Our vision is that any patient, no matter where they are located, should be able to participate in clinical trials at home and with their own doctors. This is made possible through a unique suite of tools Curebase’s has designed to engage patients in clinical trials across all settings, be it at home, at their local clinic, or other places in their community.

Daiichi Sankyo is a global pharmaceutical company with corporate origins in Japan. We provide innovative products and services in more than 20 countries around the world. With more than 100 years of scientific expertise, our company draws upon a rich legacy of innovation and a robust pipeline of promising new medicines to help patients. Through the outstanding knowledge and commitment of our 15,000 employees worldwide, we create innovative new and generic medicines, and new methods of drug discovery and delivery. We share a passion for innovation, as well as compassion for the patients around the world who are in need of our medicines.

Datacubed Health is a pioneering patient engagement and data collection company making better science and healthier communities a reality. Datacubed applies individualized smartphone solutions for the capture of ePRO and eCOA data, passive data collection, instrument delivery, wearables, and environmental sensors. Focusing on healthcare and life sciences, Datacubed Health offers software and services based on behavioral science to improve patient retention and compliance, resulting in better data and positive health outcomes.

Headquartered in Houston, DM Clinical is a clinical site network with a 15-year track record of excellence. DM Clinical conducts complicated Phase I-IV clinical trials in a broad range of therapeutic areas and specialize in vaccines. DM Clinical represents quality care and results, delivering on enrollment goals, and diverse patient populations.

Endo International plc (NASDAQ: ENDP) is a highly focused specialty branded and generics pharmaceutical company delivering quality medicines to patients in need through excellence in development, manufacturing and commercialization. Endo has global headquarters in Dublin, Ireland. Learn more at www.endo.com.

EQRx is a new type of pharmaceutical company committed to developing and expanding access to innovative medicines for some of the most prevalent disease areas, including cancer and immune-inflammatory conditions.

Flourish Research is a fully integrated clinical trial company in North America. It acquires and operates large, best-in-class sites with the very best medical and scientific expertise, meaningful diversity, and reliable recruitment.

GlaxoSmithKline – one of the world’s leading research-based pharmaceutical and healthcare companies – is committed to improving the quality of human life by enabling people to do more, feel better, and live longer. www.gsk.com

Greenphire is the global leader in financial software for clinical trials. Greenphire’s best-in-class solutions optimize clinical trial performance by streamlining financial and logistical workflows from sponsors and CROs to sites and patients. Greenphire’s ClinCard and eClinicalGPS solutions easily handle any type of trial design and complexity, resulting in more accurate and compliant payments globally for both sites and patients. ConneX is the most personalized clinical trial travel solution designed specifically to meet the recruitment and retention goals of domestic and international clinical trials. The choice of industry leaders worldwide, Greenphire provides better performance and better data, resulting in better trials. www.greenphire.com.

H1 provides the largest global healthcare network to help life sciences companies find clinical research, locate industry experts, and benchmark their organization. As the trusted source of information on healthcare professionals and institutions, H1 connects the entire healthcare ecosystem through real-time data and clinical findings. Learn more at https://h1.co/

ICON is the world’s leading clinical research organisation, powered by healthcare intelligence. From molecule to medicine, we advance clinical research providing outsourced development and commercialisation services to pharmaceutical, biotechnology, medical device and government and public health organisations. We develop new innovations, drive emerging therapies forward and improve patient lives. With headquarters in Dublin, Ireland, ICON employed approximately 40,500 employees in 119 locations in 53 countries as at June 30, 2022. For further information about ICON, visit: www.iconplc.com.

IMA Clinical Research partners in the development of new medical treatments through a flexible, full-service clinical trial site network. This includes 13 sites dedicated to clinical research across multiple therapeutic areas and over 125 satellite locations, providing diverse patient access across 40 states reaching approximately 50% of the US population. Additionally, our rapidly growing database of over 300,000 patients can reach millions. Finally, we use a modern, tech-enabled operating model to deliver various study designs, including classic site-based, hybrid and fully decentralized trials. Coupled with centralized contracting and rigorous regulatory adherence, we’re uniquely positioned to deliver quick startup and high-quality studies across our network.

IQVIA (NYSE:IQV) is a leading global provider of information, innovative technology solutions and contract research services dedicated to using analytics and science to help healthcare stakeholders find better solutions for their patients. Solutions are powered by the IQVIA CORE™, which combines big data, advanced technology, analytics and extensive industry knowledge. Formed through the merger of IMS Health and Quintiles, IQVIA has approximately 55,000 employees worldwide. Learn more at iqvia.com.

At Janssen, we are dedicated to addressing some of the most important unmet medical needs in oncology, immunology, neuroscience, infectious diseases and vaccines, and cardiovascular and metabolic diseases. Driven by our commitment to patients, we develop innovative products, services and healthcare solutions to help people throughout the world. Janssen-Cilag International NV is part of the Janssen Pharmaceutical Companies of Johnson & Johnson. www.janssen.com

Javara, the leading Integrated Research Organization (IRO), partners with large healthcare organizations to deliver clinical trial access at the point of care, reaching patients through their trusted physician by integrating research staff and infrastructure. Our broad diverse patient populations ensure clinical trials are completed with high enrollment and retention for quality data delivery. Javara’s centralized resources and standardized operations provide efficiencies for accelerated study start-up and quality outcomes, so fewer obstacles stand in the way of the product approval process. As pioneers of Clinical Research as a Care Option (CRAACO), Javara is transforming healthcare and changing lives through a reimagined approach to clinical trials. For more information, please visit javararesearch.com and follow us on LinkedIn, Twitter, and Facebook.

As the drug development business of Laboratory Corporation of America Holdings (Labcorp) and the world’s most comprehensive drug development CRO service company, we have helped pharmaceutical and biotech companies develop 100% of the top 50 prescription drugs in the marketplace today. Because of our broad experience and specialized expertise, we’re in a unique position to supply insights that go above and beyond testing. Together with our clients, we create solutions that transform potential into reality.

Lilly is a global healthcare leader that unites caring with discovery to make life better for people around the world. We were founded more than a century ago by a man committed to creating high quality medicines that meet real needs, and today we remain true to that mission in all our work. Across the globe, Lilly employees work to discover and bring life-changing medicines to those who need them, improve the understanding and management of disease, and give back to communities through philanthropy and volunteerism. To learn more about Lilly, please visit us at www.lilly.com and newsroom.lilly.com/social-channels.

Medable’s vision is to solve one of the longest-standing challenges in healthcare: biological access to clinical trials. This is realized through a decentralized clinical trial platform that’s proven to shorten trial timelines, create operational efficiencies, and expand trial access to everyone, everywhere. To learn more about us visit www.medable.com

Medidata is the leading global provider of cloud-based solutions for clinical research in life sciences, transforming clinical development through its advanced applications and intelligent data analytics. The Medidata Clinical Cloud™ brings new levels of productivity and quality to the clinical testing of promising medical treatments, from study design and planning through execution, management and reporting. www.mdsol.com

Medpace is a global full-service clinical research organization (CRO) providing Phase I-IV core development services for drug, biologic, and device programs. Medpace has strong experience supporting development programs across therapeutic areas including oncology, cardiovascular, metabolic/diabetes, infectious diseases and vaccines, neuroscience, regenerative medicine, gastrointestinal diseases, pediatrics, and orphan disease. From feasibility, research site compatibility, safety, and logistics, Medpace brings efficiencies and operational excellence to both drug and device development programs. www.medpace.com

At Medrio, we know it takes a global village to achieve a healthier world. Since 2005, we’ve developed a successful ecosystem of visionary people like you who want to change the world – employees, customers, and partners alike. Our flexible eClinical suite consists of EDC, ePRO, eConsent, Direct Data Capture, and RTSM, and provides the most complete and accurate data in a traditional, hybrid, or virtual trial environment. We’ve supported sponsors, CROs, and sites from across the life sciences industry spectrum. With our help, they have secured more than 375 approvals and achieved critical breakthroughs. Our expertise spans all therapeutic areas and phases of clinical trials. We aim to deliver the best customer experience possible because your success is our success. Learn how we do it at www.medrio.com.

Merck & Co., Inc., Whitehouse Station, NJ, USA is a global healthcare leader working to help the world be well. Through our prescription medicines, vaccines, biologic therapies, and consumer care and animal health products, we work with customers and operate in more than 140 countries to deliver innovative health solutions. We also demonstrate our commitment to increasing access to healthcare through far-reaching policies, programs and partnerships. For more information, visit www.merck.com and connect with us on Twitter, Facebook, and YouTube.

Moderna, Inc., based in Cambridge, MA, is a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines. Moderna’s mRNA platform builds on continuous advances in basic and applied mRNA science, delivery technology and manufacturing, and has allowed the development of therapeutics and vaccines for infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. For more information, visit www.modernatx.com.

As the market leading developer and delivery engine for decentralized clinical trials (DCT), MRN understands the complexities of today’s clinical trial environment and the burdens they place on patients, sites and clients.

Our services are designed to ease these burdens, from community healthcare professionals offering in-home clinical visits through to investigator site professional support, with all the expected support processes, systems and networks, all aimed at accelerating patient recruitment and increasing retention.

We work to maximize the efficiency of clinical trials, by improving the patient’s experience, no matter where their community is in the world.

MRN’s innovative services provide an unparalleled approach to decentralized clinical trials for our clients, expanding the geographical reach and demographic potential of our site partners and allowing more patients greater access to trials.

Since 2006 we have been designing bespoke trial solutions and allying with sites and drug developers to keep the patient at the center of every clinical trial.

Novo Nordisk is a global healthcare company, founded in 1923 and headquartered just outside of Copenhagen, Denmark. Our purpose is to drive change and defeat diabetes and other serious chronic diseases such as obesity, and rare blood and rare endocrine diseases. For more information visit, www.novonordisk.com, Facebook, Instagram, Twitter.

Oracle Health Sciences breaks down barriers and opens new pathways to unify people and processes to bring new drugs to market faster. As a leader in Life Sciences technology, Oracle Health Sciences is trusted by 29 of the top 30 pharma, 10 of the top 10 biotech and 10 of the top 10 CROs for managing clinical trials and pharmacovigilance around the globe. www.oracle.com/lifesciences.

Parexel is among the world’s largest clinical research organizations (CROs), providing the full range of Phase I to IV clinical development services to help life-saving treatments reach patients faster. Leveraging the breadth of our clinical, regulatory and therapeutic expertise, our team of more than 19,000 global professionals works in partnership with biopharmaceutical leaders, emerging innovators and sites to design and deliver clinical trials with patients in mind, increasing access and participation to make clinical research a care option for anyone, anywhere. Our depth of industry knowledge and strong track record gained over the past 40 years is moving the industry forward and advancing clinical research in healthcare’s most complex areas, while our innovation ecosystem offers the best solutions to make every phase of the clinical trial process more efficient. With the people, insight and focus on operational excellence, we work With Heart^TM every day to treat patients with dignity and continuously learn from their experiences, so every trial makes a difference. For more information, visit parexel.com and follow us on LinkedIn, Twitter, Facebook and Instagram. 

At Pfizer, we apply science and our global resources to bring therapies to people that extend and significantly improve their lives. We strive to set the standard for quality, safety, and value in the discovery, development and manufacture of health care products. Our global portfolio includes medicines and vaccines as well as many of the world’s best-known consumer health care products. We collaborate with health care providers, governments, and local communities to support and expand access to reliable, affordable health care around the world. For more than 150 years, Pfizer has worked to make a difference for all who rely on us. www.pfizer.com

The PPD clinical research business of Thermo Fisher Scientific enables customers to enhance innovation and drug development productivity. Utilizing patient-centered strategies and data analytics, we cover multiple therapeutic areas and include early development, all phases of clinical development, peri- and post-approval, novel approaches to patient recruitment and investigator sites, and comprehensive laboratory services. thermofisher.com/ppd

ProofPilot supports clinical trials with the industry’s first fully automated digital protocol platform. The platform orchestrates stakeholder tasks and technology, optimizing clinical workflows, improving stakeholder experiences, and maximizing data quality. Eliminating guesswork and protocol deviations creates high-performance experiences for sites and patients. Founded in 2014, ProofPilot was one of the first global digital clinical trial solutions enabling flawless execution of virtual, hybrid, and in-person research offerings with its patient and site Co-Pilot packages. Learn more at https://www.proofpilot.com

RealTime Software Solution is a global leader in SAAS-based Clinical Trials Management Systems for Sites, Sponsors, and CROs. RealTime is also the only CTMS vendor that can offer a complete suite of solutions into a seamless platform, SOMS (Site Operations Management System). SOMS includes the industry-leading CTMS, SitePAY, TEXT, eDOCS, and eSOURCE which is accessible through an easy-to-use MobileAPP. RealTime also has the most advanced multi-site and site network enterprise systems available anywhere. With an international customer base, multiple integrations with other vendors, advanced recruitment systems, intuitive monitoring portals, Outlook integration, a powerful MobileAPP and more; the team at RealTime has made a significant impact on the efficiency of the clinical research process from start to finish.

Regeneron is a leading biotechnology company that invents life-transforming medicines for people with serious diseases. Founded and led for over 30 years by physician-scientists, our unique ability to repeatedly and consistently translate science into medicine has led to eight FDA-approved treatments and numerous product candidates in development, all of which were homegrown in our laboratories. Our medicines and pipeline are designed to help patients with eye diseases, allergic and inflammatory diseases, cancer, cardiovascular and metabolic diseases, pain, infectious diseases and rare diseases. For additional information about the company, please visit www.regeneron.com

Roche is the world’s largest biotech company, with truly differentiated medicines in oncology, immunology, infectious diseases, ophthalmology and diseases of the central nervous system. Roche is also the world leader in in vitro diagnostics and tissue-based cancer diagnostics, and a frontrunner in diabetes management. The combined strengths of pharmaceuticals and diagnostics under one roof have made Roche the leader in personalised healthcare – a strategy that aims to fit the right treatment to each patient in the best way possible. For more information, please visit www.roche.com.

Sanofi, a global healthcare leader, discovers, develops and distributes therapeutic solutions focused on patients’ needs. Sanofi has core strengths in the field of healthcare with seven growth platforms: diabetes solutions, human vaccines, innovative drugs, consumer healthcare, emerging markets, animal health and the new Genzyme. Sanofi is listed in Paris (EURONEXT: SAN) and in New York (NYSE: SNY). www.sanofi.us

The speed, quality, and integrity of endpoint evidence is everything in being able to efficiently advance an experimental therapy forward. Signant is the evidence generation company that helps you digitally enable trials. No matter how or where you run your trials. We make the patient journey more natural and intuitive, and the data journey more direct and objective. With our SmartSignals ecosystem, Signant delivers proof at the speed of life, simplifying and streamlining data generation and reducing the reliance on paper-based evidence gathering and management. We offer vision at a time of change as well as reliability and dependability where it matters most. When the world is counting on you, count on Signant.

Syneos Health is the only fully integrated biopharmaceutical solutions organization. Our company, including a Contract Research Organization (CRO) and Contract Commercial Organization (CCO), is purpose-built to accelerate customer performance to address modern market realities. Created through the merger of two industry-leading companies – INC Research and inVentiv Health – we bring together more than 21,000 clinical and commercial minds with the ability to support customers in more than 110 countries. Together we share insights, use the latest technologies and apply advanced business practices to speed our customers’ delivery of important therapies to patients. To learn more about how we are shortening the distance from lab to life visit SyneosHealth.com.

Teckro transforms your protocol into a hub of communication and collaboration.  It’s a digital platform that connects all study stakeholders with the knowledge they need, when they need it. Thousands of investigators and 20,000+ sites around the world rely on Teckro to execute clinical trials from biopharma sponsors, including 12 out of the Top 20 pharma companies.

THREAD is a leading provider of a proprietary, decentralized research platform and suite of supporting services used by biopharma, CROs, and life science organizations to remotely capture data from participants and sites during, in-between, and in lieu of in-clinic visits. THREAD’s platform and supporting services are helping customers to shorten study launch timelines, reduce study budgets with Virtual Visits, and bring studies from the clinic to patients’ homes. THREAD provides key platform features such as eConsent, eCOA/ePRO, sensors, reminders, and telehealth virtual visits to support remote data capture, hybrid virtual studies, and fully decentralized studies in key therapeutic areas. In 2019, THREAD was acquired by strategic health care investors Water Street Healthcare Partners and JLL Partners. Visit www.THREADresearch.com to learn more.

Total Clinical Trial Management (TCTM), is a contract research organization based in Dallas, Texas. TCTM has a unique perspective on emphasizing the relationship with the clinical research site as a primary driver for successful clinical trial completion. TCTM has a wide range of therapeutic expertise with recent areas of focus including pain, orthopedic injury, GI, dermatology, cosmetics, over-the-counter (OTC) and generics studies.

TPS is a clinical research solutions company focused on deploying strategic resources empowered by technology; designed to address critical development needs across the industry. Our SiteChoice™ solution provides Sponsors with the ability to invest in the infrastructure of their clinical research sites, improving study conduct and quality while enhancing the patient recruitment and experience.

Velocity Clinical Research is wholly owned and dedicated solely to clinical research networks that connects researchers, doctors, and patients with the shared goal of bettering research across the industry – all in one place. We are a true “one stop shop” for high quality research and results. Each of our research facilities focuses solely on conducting clinical trials and collecting the most accurate data possible. Research should never be an afterthought. At Velocity, it’s the priority.

Vertex is a global biotechnology company that aims to discover, develop and commercialize innovative medicines so people with serious diseases can lead better lives. Founded in 1989 in Cambridge, Mass. and headquartered in Boston’s Innovation District, Vertex today has research and development sites and commercial offices in the United States, Europe, Canada and Australia. In addition to our clinical development programs focused on cystic fibrosis, Vertex has more than a dozen ongoing research programs aimed at other serious and life-threatening diseases. Vertex collaborates with some of the world’s largest pharmaceutical companies, leading nonprofit disease foundations and many of the world’s best-known academic institutions. www.vrtx.com

ZS is a professional services firm that works side by side with companies to help develop and deliver products that drive customer value and company results. We leverage our deep industry expertise, leading-edge analytics, technology and strategy to create solutions that work in the real world. With more than 37 years of experience and 10,000-plus ZSers in 28 offices worldwide, we’re passionately committed to helping companies and their customers thrive. To learn more, visit www.zs.com or follow us on Twitter and LinkedIn.